Profile
| Metric | Value |
|---|---|
| Full Name | Kura Oncology, Inc. |
| Ticker | NASDAQ: KURA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kuraoncology.com |
| Employees | 192 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $7.83 | |
| Price, 1D Change | +5.81% | |
| $681M | ||
| - | ||
| - | ||
| 0.98 | ||
| $54M | ||
| Revenue, 1Y Change | +100.00% | |
| -$2.02 | ||
| EPS, 1Y Change | +3.12% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.02 | ||
| EPS Estimate | -$2.49 | |
| EPS Est. Change | -23.20% | |
| $53.88M | ||
| Revenue Estimate | $101.22M | |
| Revenue Est. Change | +87.85% | |
| Current Price | $7.83 | |
| Price Target | - | $28.00 |
| Price Tgt. Change | - | +257.60% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.08 | -$2.08 | -0.21% | |
| -$2.41 | -$2.02 | +16.28% | |
| -$2.49 | N/A | -23.20% | |
| -$2.60 | N/A | -28.98% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $57.96M | $53.88M | -7.04% | |
| $101.22M | N/A | +87.85% | |
| $157.56M | N/A | +192.41% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $7.83 | |
| $8.19 | ||
| SMA 200 vs Price | +4.57% | |
| $9.87 | ||
| SMA 50 vs Price | +26.06% | |
| 0.98 | ||
| $0.45 | ||
| 36.52 | ||
| 61.74% | ||
| 61.95% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $53.88M | ||
| -$2.02 | ||
| $53.04M | ||
| 98.43% | ||
| -$193.20M | ||
| -358.55% | ||
| -$173.98M | ||
| -322.89% | ||
| -$192.35M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 9.46 | ||
| 9.46 | ||
| - | ||
| - | ||
| -0.35 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.55 | ||
| 2.81 | ||
| -0.63 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $413.64M | ||
| $224.46M | ||
| $1.04B | ||
| $744.83M | ||
| $627.04M | ||
| $78.71M | ||
| $16.59M | ||
| $4.49M | ||
| $1.47M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $227.87M | ||
| $246.23M | ||
| $848.00K | ||
| $0.00 | ||
| $848.00K | ||
| $0.00 | ||
| $2.02M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $134.32M | ||
| -$101.59M | ||
| $154.42M | ||
| $472.00K | ||
| $133.85M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| Wedbush | → | |
| UBS | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | ||
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with KURA
FAQ
What is the ticker symbol for Kura Oncology, Inc.?
The ticker symbol for Kura Oncology, Inc. is NASDAQ:KURA
Does Kura Oncology, Inc. pay dividends?
No, Kura Oncology, Inc. does not pay dividends
What sector is Kura Oncology, Inc. in?
Kura Oncology, Inc. is in the Healthcare sector
What industry is Kura Oncology, Inc. in?
Kura Oncology, Inc. is in the Biotechnology industry
What country is Kura Oncology, Inc. based in?
Kura Oncology, Inc. is headquartered in United States
When did Kura Oncology, Inc. go public?
Kura Oncology, Inc. initial public offering (IPO) was on September 16, 2015
Is Kura Oncology, Inc. in the S&P 500?
No, Kura Oncology, Inc. is not included in the S&P 500 index
Is Kura Oncology, Inc. in the NASDAQ 100?
No, Kura Oncology, Inc. is not included in the NASDAQ 100 index
Is Kura Oncology, Inc. in the Dow Jones?
No, Kura Oncology, Inc. is not included in the Dow Jones index
When was Kura Oncology, Inc. last earnings report?
Kura Oncology, Inc.'s most recent earnings report was on November 4, 2025
When does Kura Oncology, Inc. report earnings?
The next expected earnings date for Kura Oncology, Inc. is February 26, 2026
Data Sources & References
- KURA Official Website kuraoncology.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1422143/000119312525263589/0001193125-25-263589-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1422143/000095017025029975/0000950170-25-029975-index.htm
- KURA Profile on Yahoo Finance finance.yahoo.com/quote/KURA
- KURA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kura